Phosphodiesterase Type 5 Inhibitors for the Treatment of Male Lower Urinary Tract Symptoms

Both lower urinary tract symptoms due to benign prostatic hyperplasia (BPH) and erectile dysfunction have a very high prevalence among aging men, and there is some clinical evidence that they may share a common pathophysiology. Consequently, several preliminary studies of phosphodiesterase type 5 in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kaplan, Steven A, Gonzalez, Ricardo R
Formato: Artigo
Lenguaje:Inglês
Publicado: MedReviews, LLC 2007
Materias:
Treatment Update
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC1892621/
https://ncbi.nlm.nih.gov/pubmed/17592540
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares